What happens to women with preeclampsia? Microalbuminuria and hypertension following preeclampsia

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 36, Issue 3, 1996, Pages 233-238

  North, R A ^a,b   Simmons, D ^a   Barnfather, D ^a   Upjohn, M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b NATIONAL WOMEN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MICROALBUMINURIA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; SAMOAN ISLANDS;

EID: 0029757277     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.1996.tb02702.x     Document Type: Conference Paper

References (16)

1. Chesley LC, JE, Cosgrove RA. The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol 1976; 124: 446-459.
2. Reiter L, Brown MA, Whitworth JA. Hypertension in pregnancy: The incidence of underlying renal disease and essential hypertension. Am J Kid Ds 1994; 24: 883-887.
3. Lindeberg S, Axelsson O, Jorner U, Malmberg L, Sandstrom B. A prospective controlled five-year follow-up study of primiparas with gestational hypertension. Acta Obstet Gynecol Scand 1988; 67: 605-609.
4. Sibai BM, El-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia m young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986; 155: 1011-1016.
5. Gilbert RE, Cooper ME, McNally PG, O'Brien RC, Taft J, Jerums G. Microalbuminuria: Prognostic and therapeutic implications in diabetes mellitus. Diabetic Med 1994; 11: 636-645.
6. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M. Microalbuminuria precedes the development of NIDDM. Diabetes 1994; 43: 552-557.
7. Decken T, Kofoed-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T. Microalbuminuria. Implications for micro- and macrovascular disease. Diabetes Care 1992; 15: 1181-1191.
8. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988; 530-533.
9. Haffner SM, Stern MP, Kozlowski Gruber K, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors nondiabetic subjects? Arteriosclerosis 1990; 10: 727-731.
10. Stone P, Cook D, Hutton J, Purdie G, Murray H, Harcourt L. Measurements of blood pressure, oedema and proteinuria in a pregnant population of New Zealand Aust NZ J Obstet Gynaecol 1995; 35: 32-37.
11. Metcalf PA, Baker JR, Scraff RKR, Dryson E, Scott AJ, Wild CJ. Microalbuminuria in a middle-aged workforce: Effect of hyperglycemia and ethnicity. Diabetes Care 1993; 16: 1485-1493.
12. Simmons D, Gatland B, Fleming C, Leakehe L, Scragg R. Prevalence of known diabetes in a multiethnic community. NZ Med J 1994; 107: 219-222.
13. Baker J, Metcalf P, Scragg R, Johnson R. Fructosamine test-plus, a modified fructosamine assay evaluated. Clin Chem 1991; 37: 552-556.
14. Bianchi S, Bigazzi R, Valtriani C et al. Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension 1994; 23 (part 1): 681-687.
15. Pedrinelli R, Giampietro O, Carmassi F et al. Microalbuminuria and endothelial disfunction in essential hypertension Lancet 1994; 344: 14-18.
16. Connell SJ, Hollis S, Tieszen KL, McMurray JR, Dornan TL. Gender and the clinical usefulness of the albumin:creatinine ratio. Diabetic Med 1994; 11: 32-36